-
10007133-5Furan fatty acids are unique, naturally occurring lipids that are found in significant amounts in dietary phospholipids, such as in salmon roe. CMPF is an endogenous metabolite of furan fatty acids in humans.
-
10007133-500Furan fatty acids are unique, naturally occurring lipids that are found in significant amounts in dietary phospholipids, such as in salmon roe. CMPF is an endogenous metabolite of furan fatty acids in humans.
-
9001871-1An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-10An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-5An internal standard for the quantification of CMPF by GC- or LC-MS.
-
9001871-500An internal standard for the quantification of CMPF by GC- or LC-MS.
-
CMVAQP-BAnalytical Q panels are intended for use in the validation and verification of molecular diagnostic assays, helping to establish the LOD and ensuring the assay is linear throughtout the dynamic range. This dedicated Analytical Q Panel is designed to
-
CMVMQC-BAs a true third party control, assay drift is detected, monitored and managed, helping to ensure accurate and reliable results. This dedicated, positive run control is designed for use in monitoring the performance of molecular assays used in the
-
CMVMQP-BMolecular Q panels consist of four individual levels, including a negative and are intended to evaluate an assay's clinical range.This dedicated Molecular Q Panel is designed to monitor the performance of molecular assays used in the detection of
-
14618-10A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
14618-25A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).
-
14618-5A competitive, non-NMDA glutamate receptor antagonist (IC<sub>50</sub>s = 0.3 and 1.5 &muM for AMPA and kainate receptors, respectively, versus IC<sub>50</sub> = 25 &muM for NMDA receptors).